The Clinical Psychedelic Lab

Welcome to
The Clinical Psychedelic Lab

Australia's first psychedelic lab, leading a rigorous program of research in psychedelic medicine that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms.

The Lab is led by Dr Paul Liknaitzky.

The Lab is part of both the Turner Institute for Brain and Mental Health within the School of Psychological Sciences, and the Department of Psychiatry within the School of Clinical Sciences.

Latest announcement: MAPS Therapist Training in Australia!

The Clinical Psychedelic Lab is delighted to announce that we will host an in-person MDMA-assisted Therapist Training for mental healthcare professionals for the first time in Australia, delivered by the Multidisciplinary Association for Psychedelic Studies (MAPS).

Please note, APPLICATIONS CLOSE 21 APRIL 2023. For details and application form, click here.